Beacon Oncolytic Viruses Database Summary
- Unrivalled comprehensive & accurate preclinical and clinical Oncolytic Virus drug, trial and commercial data.
- Access to 650+ Drugs, 600+ Trials, 550+ Companies, and 450+ Deals in the Oncolytic Viruses space
- Market leading ontologies, enabling precise navigation of specific Oncolytic Viruses
- Manually curated by Oncolytic Virus scientists, with data updated daily
- Your one stop shop for Oncolytic Viruses intelligence data
Why Beacon Oncolytic Viruses Database?
Advanced Search Filtering
Drill down into Beacon’s Oncolytic Viruses drug and trial data with a unique selection of >30 search filters. Segment the Oncolytic Viruses drug and trial landscape to identify the data that matters most to you. Our filters include:
Drug Target
Drug Modality
Disease Indication
Oncolytic Virus Type
Virus Family
Viral Genome Type
Drug Status
Drug & Trial Milestones
Trial Phase & Location
How Beacon Oncolytic Virus Database Can Help You?
Track preclinical development status of oncolytic virotherapies categorised by viral families to gain a fundamental understanding of the most prevalent and promising assets in the field.
Leverage Beacon’s unique data filter to quickly gain an overview of the distribution of various delivery methods for oncolytic virus-based therapies in the field.
Beacon’s comprehensive data on companies and deals enables you to stay up to date on all preclinical and clinical assets within each company’s portfolio, helping you maintain competitive advantages.
Beacon Oncolytic Viruses Database: The Numbers
Beacon Oncolytic Virus Database: Key Data Segments
Drug Data
Revolutionize your landscape searching for Oncolytic Viruses.
Utilize >20 search filters to find programs based on disease indication, drug modality, Oncolytic Virus type, virus family, viral genome type, and many more.
Trial Data
Optimize your Oncolytic Virus clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the Oncolytic Virus trial landscape based on drug technologies, combination trials, trial locations, trial phase, disease indication and more.
Milestones
A unique Oncolytic Virus development milestone filter and visualization tool.
Track past, present, and future Oncolytic Virus drug development milestones, including drug and trial readouts, asset history, and regulatory announcements.
Company Data
Your centralized location for Oncolytic Virus company intelligence
Identify competitors and business development opportunities, using unique company filters including, company type, HQ locations, operating status & latest funding round, and technologies / diseases targeted in their pipeline.
Deal Data
De-risk your Oncolytic Virus partnership & fundraising projects
Search Oncolytic Virus deals using custom search filters based on drug technologies involved, deal value & upfront payments, deal types to filter M&As, financing & partnership / licensing deals, geographic market, funding type, and many more.
Beacon Oncolytic Viruses Database: Drug Modalities
Analyze 650+ drugs (preclinical and clinical) and 600+ clinical trials (from early to late stage).
Beacon Oncolytic Viruses is a manually curated database solution that includes all publicly available data for preclinical, active, approved, and discontinued virus-based therapies being developed for oncology indications. The database covers:
- Genetically modified or naturally occurring oncolytic virus-based therapies
- Virus based therapeutics including therapeutic viral-vaccines
Beacon Oncolytic Viruses also includes a host of preclinical data including, cell line and animal model experimental data.
Who is Beacon Oncolytic Viruses Database For?
Beacon Oncolytic Viruses is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug, trial and commercial data, offering unrivalled insight into the Oncolytic Viruses development landscape.
Scientific Strategy Leader
Select the right pipeline for your Oncolytic Virus drug development
Research Scientist
Validate new targets & inform your Oncolytic Virus design
Clinical Development
Design optimized Oncolytic Virus clinical trials & benchmark against the competition
Business Development
Uncover new Oncolytic Virus licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging Oncolytic Virus technologies
Translational Development
Confidently take your preclinical Oncolytic Virus into the clinic
Related Solutions
Check out additional solutions available from Beacon
Related Resources
Check out Oncolytic viruses related resources available from Beacon
Our Experts
Mindy Tomczak
Lead Research Analyst
Charlie De Lanoy Meijer
Account Manager
Frank Plowden
